BeckerM.H. (Ed.): The health belief model and personal health behavior, Health Educ. Monogr.2: 324–473, Winter 1974.
2.
BeckerM.H.GreenL.W.: A family approach to compliance with medical treatment: A selective review of the literature, Int. J. Health Educ.18: 173–182, 1975.
3.
FadenR.H.: Informed consent: A psychosocial paradigm. Doctoral dissertation, University of California, Berkeley1975.
4.
GillumR.F.BarskyA.J.: Diagnosis and management of patient noncompliance, JAMA228: 1563–1567, 1974.
5.
SackettD.L.HaynesR.B.: Compliance with therapeutic regimens. Johns Hopkins University Press, Baltimore, 1976.
6.
SharpeT.R.MikealR.L.: Patient compliance with prescription medication regimens, J. Am. Pharm. Assoc.15: 191–197, 1975.
7.
StimsonG.V.: Obeying doctor's orders: A view from the other side, Soc. Sci. Med.8: 97–104, 1974.
8.
SchmidtA.M.: Dimensions of change in FDA. FDA Consumer reprint. DHEW Publ. No. (FDA) 74–3008, Oct. 1973.
9.
McMahonF.G.: The patient package insert, JAMA233: 1089, 1975.
10.
Food and Drug Administration: Proposed rules: Estrogens for general use, Fed. Reg.41: 43108–43123, 1976.
11.
CapinA.M.: Informed consent in catastrophic disease research and treatment, Univ. Pa. Law Rev.123: 340–438, 1974.
12.
FreidmanB.: A moral theory for informed consent, Hastings Cent. Rep.32–39, Aug. 1975.
13.
MillJ.S.: On liberty. John W. Parker and Son, London, 1859.
14.
FinebergT.: Social Philosophy. Prentice-Hall, Englewood, N.J., 1973.
15.
FleckensteinL.JoubertP.LawrenceR.PastnerB.MazzulloJ.M.LasagnaL.: Oral contraceptive patient information: A questionnaire study of attitudes, knowledge, and preferred information sources, JAMA235: 1331–1336, 1976.
16.
HulkaB.KupperL.L.CasselJ.C.: Medication use and misuse: Physician-patient discrepancies, J. Chronic Dis28: 7–21, 1975.
17.
GreenL.W.WerlinS.H.SchaufflerH.H.AveryC.H.: Research and demonstration issues in self-care: Measuring the decline of medicocentrism. Arthur D. Little, Boston, 1976.
18.
LeyP.: Communication in the clinical setting, Br. J. Orthod.1: 173–177, 1974.
19.
LeyP.: The measurement of comprehensibility, J. Inst. Health Educ.11: 17–20, 1973.
20.
LeyP.BradshawP.W.EavesD.WalkerC.M.: A method for increasing patients' recall of information presented by doctors, Psychol. Med.3: 217–220, 1973.
KintschW.: Learning, memory, and conceptual processes. Wiley, New York, 1970.
24.
LeyP.SpelmanM.S.: Communicating with the patient. Staples Press, London, 1967.
25.
LeyP.: Primacy, rated importance, and the recall of medical statements, J. Health Soc. Behav.13: 311–317, 1972.
26.
PyrczakF.RothD.H.: The readability of directions on nonprescription drugs, J. Am. Pharm. Assoc.16:242–243;267, 1976.
27.
EatonD.: N.I.E. attacks the reading and language skills problem. In: Research developments. Reprinted by the National Institute of Education from Am. Educ, May 1974.
28.
LouisdellD.W.: Medical malpractice. Mathew Benilar, New York, 1973.
29.
BeecherH.K.: Consent in clinical experimentation: Myth and reality, JAMA195:34–35; 124, 1966.
30.
MooreF.D.: Therapeutic innovation: Ethical boundaries in the initial clinical trials of new drugs and surgical procedures, Daedalus98: 502–511, 1969.
31.
WaltzJ.R.ScheunemanT.W.: Informed consent to therapy, Northwest. Univ. Law Rev.64: 628–650, 1969.
32.
GlassE.S.: Restructuring informed consent: Legal therapy for the doctor-patient relationship, Yale Law J.79: 1533, 1970.
33.
GaylinW.: The patient's Bill of Rights, Sat. Rev. Sei.1: 22, 1973.
34.
LeyP.JainV.K.SkilbeckC.E.: An attempt to reduce patient medication errors by the provision of information leaflets. Unpublished manuscript, 1974, reported in ref. 35.
35.
LeyP.: The use of techniques and findings from social and experimental psychology to improve doctor-patient communications. In: Health education and primary care: Conference report. Department of Community Medicine and Leeds Polytechnic, Leeds, Sept. 1975.
36.
BoydJ.R.CovingtonT.R.StanaszekW.F.CoussonsT.R.: Drug defaulting II: Analysis of noncompliance patterns, Am. J. Hosp. Pharm.31: 485–491, 1974.
37.
SharpeT.R.MikealR.L.: Patient compliance with antibiotic regimens, Am. J. Hosp. Pharm.31: 479–484, 1974.
38.
FoxL.A.: Written reinforcement of auxiliary directions for prescription medications, Am. J. Hosp. Pharm.26: 334–341, 1969.
39.
SmolekR.W.: Auxiliary labeling — Better patient care, Ill. Pharm.34: 418–420, 1970.
40.
CliniteJ.C.KabatH.F.: Improving patient compliance, J. Am. Pharm. Assoc.16:74–76;85, 1976.
41.
GreenL.W.: Health education: Science, placebo or science of placebo?Century Forum Lecture, University of Vermont Medical School, Burlington, 1976.